DFE Pharma
Martti Hedman has a diverse and extensive work experience in the pharmaceutical industry. Martti currently holds the position of Chief Executive Officer at DFE Pharma since February 2022. Prior to this, they served as a Board Member at Galena Pharma Oy starting in January 2022. Martti also held the role of Member of the Board at Ecobio Oy from November 2021 onwards. Martti has a history with Colorcon, where they held various leadership positions including CEO from May 2013 to December 2020, VP - Global Commercial Operations from September 2012 to May 2013, and President of Europe, Middle East & Africa from January 2007 to September 2012. Martti started their journey at Colorcon in 1998 as the Sales & Marketing Director, EMEA, and later served as the VP of Coatings & Excipients from 2003 to 2006. Lastly, they served as an Advisor at Colorcon, Oliver-Tolas from January 2021 to December 2021. Additionally, Martti was also a Board Member at DelSiTech Ltd. from January 2022, with an end date in December 2023.
Martti Hedman obtained a Master's degree from the Turku School of Economics between 1978 and 1982.
DFE Pharma
2 followers
DFE Pharma is a global leader in pharmaceutical excipient solutions. We develop, produce and supply the highest quality functional excipients for use in the pharmaceutical, biopharmaceutical and nutraceutical industries for respiratory, oral solid dose (OSD), ophthalmic and parenteral formulations. Our excipients play an essential role as fillers, binders, disintegrants, and in stabilizing active ingredients for release in a predictable and effective manner into the patient’s system. With over a century of experience and over 400+ people worldwide in over 100 countries serving over 5,000 customers, DFE Pharma is committed to supporting (bio)pharmaceutical and nutraceutical companies in their journey to improve patients’ lives. We are driven by our purpose your medicines, our solutions. Moving to a healthier world. Learn more at www.dfepharma.com